HOME >> MEDICINE >> NEWS
Sex and prenatal hormone exposure affect cognitive performance, Yerkes scientists find

Yerkes researchers are using their findings to better understand sex differences in cognitive performance, which may lead to increased understanding of the difference in neuropsychological disorders men and women experience.

In one of the first research studies to assess sex differences in cognitive performance in nonhuman primates, researchers at the Yerkes National Primate Research Center have found the tendency to use landmarks for navigation is typical only of females.

This finding, which corroborates findings in rodents and humans and is available in the online edition of Hormones and Behavior, suggests there is not just a difference in how well females and males solve spatial problems, but also in which types of cues they use to solve such problems. Researchers are applying this knowledge to gain a better understanding of how the brain develops and functions.

Lead researcher Rebecca Herman, PhD, says the very fact females and males use different strategies suggests there are subtle sex differences in the way the brain develops. As an example of these strategies, Herman said men, when finding a location, generally use north and south as well as distance estimates whereas women prefer physical cues such as street names, signs and buildings. Herman and her collaborator Kim Wallen, PhD, believe a better understanding of how spatial memory develops in healthy women and men may provide insights into abnormal brain development and neuropsychological disorders that show sex differences in prevalence or symptoms, such as attention deficit hyperactivity disorder, Alzheimers disease and autism.

As part of the study, Herman and Wallen compared normal female and male rhesus macaques to those who differed in their prenatal exposure to androgens in order to understand if sex differences were explained by differences in hormone exposure in utero. Some females and males received a drug that blocks the actions of androgens whi
'"/>

Contact: Emily Rios
erios@rmy.emory.edu
404-727-7732
Emory University
12-Apr-2007


Page: 1 2

Related medicine news :

1. New data supports a non-invasive approach to routine prenatal genetic testing
2. Pregnant women in the dark on prenatal screening
3. New prenatal resource center at North General Hospital to open with March of Dimes support
4. Study shows that prenatal exposure to alcohol may cause visual problems in infants
5. 4D ecography for the diagnosis of prenatal cardiopathy
6. Low-carb diets effects linked to rise in newly identified starvation hormone
7. COX inhibitors may weaken protective qualities of estrogen hormone therapy
8. UW study to clarify safety, effectiveness of hormone therapy during menopause
9. Alternative hormone treatment could help fight against breast cancer
10. Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
11. Your brain and hormones may conspire to make you fat

Post Your Comments:
(Date:5/5/2015)... Alachua, FL (PRWEB) May 05, 2015 ... technology company focused on the $1.6 billion peripheral nerve ... the first quarter ended March 31, 2015 compared to ... “The market’s continued adoption of our proprietary portfolio of ... Nerve Connector and AxoGuard® Nerve Protector – and our ...
(Date:5/5/2015)... 2015 Leveraging the industry-leading technology found ... an experienced team of fertility specialists are committed to ... around the globe. , “We’re honored that Maternity Health ... a global leader in reproductive medicine. The clinic offers ... in the world who play an important role in ...
(Date:5/5/2015)... global lab automation market is expected to reach $5,105.7 ... an estimated CAGR of 6.7% from 2015 to 2020. ... basis of equipment and software, application, type of automation, ... Lab Automation Market is classified into clinical diagnostics, drug ... a major application of the lab automation market. Developing ...
(Date:5/5/2015)... 05, 2015 Hundreds of ... on behalf of men who allegedly suffered ... of prescription testosterone replacement therapies continue to ... underway in U.S. District Court, Northern District ... May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, ...
(Date:5/5/2015)... Viverae®, a health management and engagement ... multinational developer, manufacturer and marketer of innovative, life-enhancing ... oncology and surgical specialty products, as the recipient ... Award recognizes outstanding achievement in the design and ... client base. , Viverae reviewed the employee wellness ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2
(Date:5/5/2015)... 2015 Ardelyx, Inc. (NASDAQ: ARDX ... gastrointestinal, and metabolic diseases, today announced that a ... Stage 3 chronic kidney disease patients with type ... the primary endpoint of decreasing the urinary albumin-creatinine ... placebo. Ardelyx formed a partnership ...
(Date:5/5/2015)... -- (Family Features) Which health screenings and exams are ... monitoring your weight, cholesterol, and blood pressure is probably ... vision care? Photo - http://photos.prnewswire.com/prnh/20150505/213909 ... they often start to notice small changes in their ... performance. Whether having difficulty reading a book or working ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Electro Surgical Market" ... electrosurgical market is expected to achieve a CAGR ... surgery offer huge benefits for patients as well ... surgery infections, condensed visible marks, bleeding control and ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Global Electro Surgical Market 2015 2
Cached News: